Giraldo J
Grup Biomatemàtic de Recerca, Institut de Neurociències and Unitat de Bioestadística, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Br J Pharmacol. 2008 Sep;155(1):17-23. doi: 10.1038/bjp.2008.234. Epub 2008 Jun 9.
Mechanistic and empirical modelling are compared in context of dimeric receptors. In particular, the supposed advantages of the two-state dimer model for fitting of binding data with respect to classical approaches such as the two-independent sites model are investigated. The two models are revisited from both the mechanistic and empirical point of views. The problem of overparameterized models and the benefits of the concurrent use of mechanistic and empirical models for mechanism analysis are discussed. The pros and cons of mathematical models are examined with special emphasis given to the interpretation of the connection between the shapes of the curves and receptor cooperativity. It is shown that a given pharmacological phenotype (curve shape) can be obtained from different receptor genotypes (as, for instance, non-interconvertible monomeric receptor species, receptor-G protein interactions and dimeric receptors), though values of the Hill coefficient greater than one are indicative of receptor oligomerization. The existence of a relationship between the recently defined dimer cooperativity index and the more familiar Hill coefficient is proven.
在二聚体受体的背景下对机理模型和经验模型进行了比较。特别地,研究了二态二聚体模型在拟合结合数据方面相对于诸如双独立位点模型等经典方法的假定优势。从机理和经验两个角度重新审视了这两种模型。讨论了模型参数过多的问题以及同时使用机理模型和经验模型进行机理分析的好处。特别强调了曲线形状与受体协同性之间联系的解释,对数学模型的优缺点进行了研究。结果表明,给定的药理学表型(曲线形状)可以从不同的受体基因型(例如,不可相互转化的单体受体种类、受体 - G蛋白相互作用和二聚体受体)获得,尽管希尔系数大于1的值表明受体寡聚化。证明了最近定义的二聚体协同性指数与更为人熟知的希尔系数之间存在关系。